• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠N1-S1肿瘤的成像及经股动脉治疗的技术层面:用于测试肝癌经动脉治疗的生物学特性及治疗反应的合适模型

Technical aspects of imaging and transfemoral arterial treatment of N1-S1 tumors in rats: an appropriate model to test the biology and therapeutic response to transarterial treatments of liver cancers.

作者信息

Ju Shenghong, McLennan Gordon, Bennett Stacy L, Liang Yun, Bonnac Laurent, Pankiewicz Krzysztof W, Jayaram Hiremagalur N

机构信息

Department of Radiology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

出版信息

J Vasc Interv Radiol. 2009 Mar;20(3):410-4. doi: 10.1016/j.jvir.2008.12.408. Epub 2009 Jan 23.

DOI:10.1016/j.jvir.2008.12.408
PMID:19167243
Abstract

The present study was undertaken to assess the technical feasibility of transfemoral hepatic artery catheterization in rats and to describe the imaging techniques that can be used on tumors in rats. A total of 106 N1-S1 cells were inoculated into the left lobes of 74 rats. In 17, transfemoral angiography was attempted. Tumor volumes for 2 weeks before angiography were measured with magnetic resonance imaging in 40 animals. Tumors grew in 63 animals. Angiography was successful in 16 rats. Mean tumor volumes were 0.13 mL and 0.9 mL after 1 and 2 weeks, respectively. In conclusion, transfemoral hepatic artery catheterization is feasible in this animal model.

摘要

本研究旨在评估大鼠经股动脉肝动脉插管的技术可行性,并描述可用于大鼠肿瘤的成像技术。将总共106个N1-S1细胞接种到74只大鼠的左叶。对17只大鼠尝试进行经股动脉血管造影。40只动物在血管造影前2周用磁共振成像测量肿瘤体积。63只动物的肿瘤生长。血管造影在16只大鼠中成功。1周和2周后平均肿瘤体积分别为0.13 mL和0.9 mL。总之,在该动物模型中经股动脉肝动脉插管是可行的。

相似文献

1
Technical aspects of imaging and transfemoral arterial treatment of N1-S1 tumors in rats: an appropriate model to test the biology and therapeutic response to transarterial treatments of liver cancers.大鼠N1-S1肿瘤的成像及经股动脉治疗的技术层面:用于测试肝癌经动脉治疗的生物学特性及治疗反应的合适模型
J Vasc Interv Radiol. 2009 Mar;20(3):410-4. doi: 10.1016/j.jvir.2008.12.408. Epub 2009 Jan 23.
2
Transarterial ethanol ablation of cirrhotic liver with lipiodol-ethanol mixture: safety and efficacy study in rats.经动脉用碘油-乙醇混合物对肝硬化肝脏进行乙醇消融:大鼠安全性和有效性研究
Invest Radiol. 2006 Aug;41(8):609-17. doi: 10.1097/01.rli.0000223884.05289.c3.
3
Time-course studies of implanted rabbit VX2 liver tumors to identify the appropriate time for starting hepatic arterial embolization in animal models.对植入兔 VX2 肝肿瘤的时间进程研究,以确定在动物模型中开始肝动脉栓塞的合适时间。
Oncology. 2011;80(1-2):92-6. doi: 10.1159/000328763. Epub 2011 Jun 13.
4
Tumor response and apoptosis of N1-S1 rodent hepatomas in response to intra-arterial and intravenous benzamide riboside.N1-S1 啮齿动物肝癌经肝动脉和静脉注射苯甲酰胺核苷后的肿瘤反应和细胞凋亡。
Cardiovasc Intervent Radiol. 2012 Jun;35(3):645-52. doi: 10.1007/s00270-011-0140-z. Epub 2011 Mar 24.
5
Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.肝动脉栓塞及化疗栓塞治疗伊马替尼耐药的胃肠道间质瘤
Am J Clin Oncol. 2009 Dec;32(6):574-81. doi: 10.1097/COC.0b013e31819cca35.
6
[Basic study on hepatic artery chemoembolization using temperature-sensitive liposome in the treatment of hepatic tumor: animal experiment].[温度敏感脂质体用于肝肿瘤治疗的肝动脉化疗栓塞基础研究:动物实验]
Gan To Kagaku Ryoho. 1991 Sep;18(12):2183-5.
7
Experimental study on transarterial administration of GRGDSP combined with transarterial chemoembolization in rats with hepatic carcinoma.GRGDSP经动脉给药联合经动脉化疗栓塞治疗大鼠肝癌的实验研究
Cardiovasc Intervent Radiol. 2008 Mar-Apr;31(2):377-82. doi: 10.1007/s00270-007-9233-0. Epub 2007 Dec 4.
8
Effectivity of laser-induced thermotherapy: in vivo comparison of arterial microembolization and complete hepatic inflow occlusion.激光诱导热疗的有效性:动脉微栓塞与完全肝血流阻断的体内比较
Lasers Surg Med. 2005 Mar;36(3):238-44. doi: 10.1002/lsm.20144.
9
[Choice of the approach in catheterization and embolization of the hepatic artery in malignant tumors of the liver].[肝癌恶性肿瘤肝动脉插管及栓塞术的入路选择]
Klin Khir (1962). 1990(5):24-6.
10
The effect of transarterial prostate embolization in hormone-induced benign prostatic hyperplasia in dogs: a pilot study.经动脉前列腺栓塞术对犬激素诱导性良性前列腺增生的影响:一项初步研究。
J Vasc Interv Radiol. 2009 Mar;20(3):384-90. doi: 10.1016/j.jvir.2008.11.014. Epub 2009 Jan 20.

引用本文的文献

1
Combining Chemistry and Engineering for Hepatocellular Carcinoma: Nano-Scale and Smaller Therapies.化学与工程学结合用于肝细胞癌:纳米级及更小尺寸的治疗方法
Pharmaceutics. 2020 Dec 20;12(12):1243. doi: 10.3390/pharmaceutics12121243.
2
Factors impacting technical success rate of image-guided intra-arterial therapy in rat orthotopic liver tumor model.影响大鼠原位肝肿瘤模型中影像引导下动脉内治疗技术成功率的因素。
Am J Transl Res. 2019 Jun 15;11(6):3761-3770. eCollection 2019.
3
Angiographic Atlas of the Visceral Vascular Anatomy in Translational Rat Models.
内脏血管解剖图谱。转化大鼠模型。
J Vasc Interv Radiol. 2019 Dec;30(12):2009-2015.e1. doi: 10.1016/j.jvir.2019.03.005. Epub 2019 Jun 13.
4
Relative Initial Weight Is Associated with Improved Survival without Altering Tumor Latency in a Translational Rat Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma and Transarterial Embolization.在二乙基亚硝胺诱导的肝细胞癌和经动脉栓塞的转化大鼠模型中,相对初始体重与生存率提高相关,且不改变肿瘤潜伏期。
J Vasc Interv Radiol. 2017 Jul;28(7):1043-1050.e2. doi: 10.1016/j.jvir.2017.03.037. Epub 2017 May 9.
5
Segmental Transarterial Embolization in a Translational Rat Model of Hepatocellular Carcinoma.肝细胞癌转化大鼠模型中的节段性经动脉栓塞术
J Vasc Interv Radiol. 2015 Aug;26(8):1229-37. doi: 10.1016/j.jvir.2015.02.006. Epub 2015 Apr 8.
6
Invasive catheterization of the hepatic artery for preclinical investigation of liver-directed therapies in rodent models of liver cancer.经肝动脉侵袭性插管用于肝癌啮齿动物模型中肝脏导向治疗的临床前研究。
Am J Transl Res. 2013 Apr 19;5(3):269-78. Print 2013.
7
Spontaneous tumor regression in a syngeneic rat model of liver cancer: implications for survival studies.自发性肿瘤消退在肝癌同基因大鼠模型中的意义:对生存研究的启示。
J Vasc Interv Radiol. 2012 Dec;23(12):1685-91. doi: 10.1016/j.jvir.2012.08.025.
8
AS30D model of hepatocellular carcinoma: tumorigenicity and preliminary characterization by imaging, histopathology, and immunohistochemistry.AS30D 肝癌模型:通过影像学、组织病理学和免疫组织化学进行的致瘤性和初步特征描述。
Cardiovasc Intervent Radiol. 2013 Feb;36(1):198-203. doi: 10.1007/s00270-012-0466-1. Epub 2012 Aug 25.
9
Radiofrequency ablation: effect of tumor- and organ-specific pharmacologic modulation of arterial and portal venous blood flow on coagulation diameter in an N1-S1 tumor model.射频消融:肿瘤和器官特异性药物调节动脉和门静脉血流对 N1-S1 肿瘤模型中凝固直径的影响。
J Vasc Interv Radiol. 2012 Jun;23(6):826-32. doi: 10.1016/j.jvir.2012.02.010. Epub 2012 Apr 14.
10
Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations.开发并初步测试用于磁共振成像和介入性肿瘤学研究的肝细胞癌转化模型。
J Vasc Interv Radiol. 2012 Mar;23(3):385-95. doi: 10.1016/j.jvir.2011.11.018. Epub 2012 Jan 20.